Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. News
  7. Summary
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Gerresheimer : Annual General Meeting of Gerresheimer AG approves tenth dividend increase in a row

06/09/2021 | 08:09am EDT

Duesseldorf, June 9, 2021 - The virtual Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share. 'All of our plants around the world managed the Covid situation well last year, maintained their production operations, and continued to supply our customers with products that are so important to the healthcare industry,' Dietmar Siemssen, Chief Executive Officer of Gerresheimer AG, told the Annual General Meeting. 'We were proactive in establishing additional capacities for injection vials early on in the Covid vaccination drive. In spite of the pandemic, we opened up new opportunities for growth and laid the foundations for our accelerated growth course. We are transforming our Gerresheimer into a growth company as innovation leader and solutions provider. That transformation is well underway.'

The dividend has been increased by 4% to EUR 1.25 per dividend-entitled share. In the prior year, the company paid a dividend of EUR 1.20 per share. The dividend is to be paid out on June 14, 2021.

The actions of the Management Board and Supervisory Board for the financial year 2020 were approved by a large majority. Deloitte GmbH Wirtschaftsprüfungsgesellschaft, Duesseldorf, was elected as auditor for the financial year 2021. The Annual General Meeting confirmed the remuneration system for the Management Board members and the remuneration of the Supervisory Board members. In addition, the Annual General Meeting adopted two resolutions on creating new authorized capital.

A total of 79.11% of the capital stock was represented at today's Annual General Meeting. The detailed voting results for all items on the Annual General Meeting's agenda are available at:
https://www.gerresheimer.com/en/company/investor-relations/annual-general-meeting

The speech by the Chief Executive Officer and the presentation on the Annual General Meeting are available at:
https://www.gerresheimer.com/en/company/investor-relations/annual-general-meeting

The Annual Report is available at:
https://www.gerresheimer.com/en/company/investor-relations/reports

About Gerresheimer

Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.

Disclaimer

Gerresheimer AG published this content on 09 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 June 2021 12:08:01 UTC.


ę Publicnow 2021
All news about GERRESHEIMER AG
07/28GERRESHEIMER AT CPHI NORTH AMERICA : Innovative packaging and easy administratio..
PU
07/22GERRESHEIMER AG : Release according to Article 40, Section 1 of the WpHG [the Ge..
EQ
07/16GERRESHEIMER AG : Gets a Buy rating from DZ Bank
MD
07/15DGAP-PVR : Gerresheimer AG: Release according to -2-
DJ
07/15DGAP-PVR : Gerresheimer AG: Release according to Article 40, Section 1 of the Wp..
DJ
07/15GERRESHEIMER AG : Release according to Article 40, Section 1 of the WpHG [the Ge..
EQ
07/15GERRESHEIMER AG : Berenberg remains its Buy rating
MD
07/14DGAP-DD : Gerresheimer AG english
DJ
07/14GERRESHEIMER AG : Gets a Buy rating from Credit Suisse
MD
07/14GERRESHEIMER AG : JP Morgan reaffirms its Neutral rating
MD
More news
Financials
Sales 2021 1 466 M 1 739 M 1 739 M
Net income 2021 110 M 131 M 131 M
Net Debt 2021 971 M 1 152 M 1 152 M
P/E ratio 2021 25,1x
Yield 2021 1,48%
Capitalization 2 757 M 3 268 M 3 269 M
EV / Sales 2021 2,54x
EV / Sales 2022 2,35x
Nbr of Employees 10 032
Free-Float 100%
Chart GERRESHEIMER AG
Duration : Period :
Gerresheimer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GERRESHEIMER AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 87,80 €
Average target price 101,38 €
Spread / Average Target 15,5%
EPS Revisions
Managers and Directors
Dietmar Siemssen Chief Executive Officer
Bernd Metzner Chief Financial Officer
Axel Herberg Chairman-Supervisory Board
Theodor Stuth Member-Supervisory Board
Udo Johannes Vetter Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
GERRESHEIMER AG0.06%3 277
ABBOTT LABORATORIES10.49%214 853
MEDTRONIC PLC12.10%176 401
BECTON, DICKINSON AND COMPANY2.36%74 487
ALIGN TECHNOLOGY, INC.30.99%55 396
HOYA CORPORATION15.03%54 156